Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer-Reference-Cited by-同舟云学术

Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer

Published:2016-01 Issue:1 Volume:36 Page:62-73
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Cohen Courtney A.¹,Shea Amanda A.²,Heffron C. Lynn¹,Schmelz Eva M.²,Roberts Paul C.¹

Affiliation:

1. Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia.

2. Department of Human Nutrition, Foods, and Exercise, Virginia Polytechnic Institute and State University, Blacksburg, Virginia.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2015.0049

Reference49 articles.

1. Incidence of Ovarian Maldescent in Women With Müllerian Duct Anomalies: Evaluation by MRI

2. Ovarian tumor-initiating cells display a flexible metabolism

3. Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients

4. Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCL3: A key player in tumor microenvironment and inflammatory diseases;Life Sciences;2024-07

2. Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk;Frontiers in Immunology;2024-01-09

3. Genetic and Functional Modifications Associated with Ovarian Cancer Cell Aggregation and Limited Culture Conditions;International Journal of Molecular Sciences;2023-10-03

4. Clinical and translational advances in ovarian cancer therapy;Nature Cancer;2023-08-31

5. Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential;Exploration of Targeted Anti-tumor Therapy;2023-06-30